Alcon expects 2024 sales of $9.8 billion to $9.9 billion, compared with prior guidance of $9.9 billion to $10.1 billion. It expects core earnings per share of $3 to $3.05, compared with a previous ...

Soft multifocal lenses show promise as a management tool for accommodation and vergence disorders in patients without presbyopia.